13681-36-2

Basic information

• Product Name: (2E)-4-{[(3-chlorophenyl)carbamoyl]oxy}-N,N,N-trimethylbut-2-en-1-aminium chloride
• CAS NO: 13681-36-2
• Molecular Formula: C₁₄H₂₀Cl₂N₂O₂
• Molecular Weight: 319.2268
• Mol File: 13681-36-2.mol
• Article Data: 0

Chemical Properties

• CAS DataBase Reference: (2E)-4-{[(3-chlorophenyl)carbamoyl]oxy}-N,N,N-trimethylbut-2-en-1-aminium chloride(CAS DataBase Reference)
• NIST Chemistry Reference: (2E)-4-{[(3-chlorophenyl)carbamoyl]oxy}-N,N,N-trimethylbut-2-en-1-aminium chloride(13681-36-2)
• EPA Substance Registry System: (2E)-4-{[(3-chlorophenyl)carbamoyl]oxy}-N,N,N-trimethylbut-2-en-1-aminium chloride(13681-36-2)

Safety Data

• Hazardous Substances Data: 13681-36-2(Hazardous Substances Data)

Usage

Description

(2E)-4-[(3-chlorophenyl)carbamoyl]oxy-N,N,N-trimethylbut-2-en-1-aminium chloride, commonly known as carbocisteine, is a quaternary ammonium compound derived from the amino acid cysteine. It features a chlorophenyl group, a carbamoyl group, and three trimethylbut-2-en-1-aminium groups in its chemical structure. Carbocisteine is a medication primarily used for the treatment of chronic obstructive pulmonary disease (COPD) and other respiratory conditions.
Used in Pharmaceutical Industry:
Carbocisteine is used as a mucolytic agent for the treatment of chronic obstructive pulmonary disease (COPD) and other respiratory conditions. It functions by thinning and loosening mucus in the airways, facilitating easier expectoration. The medication is typically administered orally in the form of capsules or syrup and is associated with a low risk of side effects, making it a preferred choice for respiratory therapy.

Upstream product

• 2909-38-8 m-chlorophenyl isocyanate 
• 92546-32-2 4-Chlor-buten-(2)-yl- 
• 75-50-3 trimethylamine